Remove Bioequivalency Remove FDA Approval Remove Generic Drugs Remove Pharma Companies
article thumbnail

In the News: October Regulatory and Development Updates

Camargo

In November 2017, Foundation Medicine received approval for FoundationOne CDx , a genomic profiling test for solid state tumors, which paved the way for partnerships with pharma companies’ therapeutics. Prior to the availability of this test, Bayer struggled to find patients for its new drug.